bpc-157 for muscle recovery athletes and injury treatment: Science, safety, and legal concerns BPC-157 for Recovery Support –

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

Studies in the peptide have spurred numerous research hypotheses, which include possible sleep regulation via pineal gland stimulation, releasing more melatonin

Ask for the COA that matches the batch number on your specific vial

The peptide showed no effect on serum IGF-1 levels, no negative effect on carbohydrate metabolism, and no immunogenicity with no anti-AOD-9604 antibodies detected

The mechanisms are well-documented: promotes angiogenesis (new blood vessel formation), increases fibroblast migration to injury sites, protects tissues from oxidative damage, modulates the gut-brain axis